University of Crete (UOC)
Η έκφραση των υποδοχέων του επιδερμικού αυξητικού παράγοντα στους καπνιστές με ή χωρίς χρόνια αποφρακτική πνευμονοπάθεια
Abstract
dc:descriptionBackgroundChronic obstructive pulmonary disease (COPD) is becoming a serious health problem in the West, with an alarming increase in new cases and deaths each year. In over 95% of patients with COPD, prolonged exposure to cigarette smoke is the primary, and usually only, environmental aetiological factor for developing this disease. Cigarette smoke contains more than 4000 chemical compounds, a large number of solid particles and several free radicals that lead to oxidative stress of lung epithelium.Under normal conditions, lung epithelium is the first line of immune defence against smoking. In COPD, this natural barrier is compromised, leading to abnormal epithelial remodeling and mucociliary system dysfunction. Growth factors receptors, such as the EGFR family, play a key role in this process. Specifically, exposure of lung epithelium to oxidative stress induced by cigarette smoke stimulates aberrant epidermal growth factor receptor (ErbB) family activation. This study’s objective was to evaluate the expression of ErbB1–4 receptors in the lung tissue of smokers with or without chronic obstructive pulmonary disease (COPD). Materials and methodsERBBs expression was measured by microarray analysis in lung tissue samples from five patients with COPD and five non-COPD smokers, and by quantitative real-time PCR in additional 20 patients with COPD (GOLD stage II), 15 non-COPD smokers and 10 nonsmoker controls.Results Microarray data analysis revealed that ErbB receptors expression was elevated in patients with COPD compared to non-COPD smokers, ranging from 1.62- to 2.45-fold, (P < 0.01).Real-time qPCR verified that patients with COPD had higher ErbB1–3 expression levels compared with non-COPD smokers (PErbB1< 0.001; PErbB2 = 0.003; PErbB3 = 0.003) and nonsmokers (PErbB1 = 0.019; PErbB2 = 0.005; PErbB3 = 0.011). On the other hand, ErbB4 mRNA levels gradually increased from nonsmokers (0.74 ± 0.19) to non-COPD smokers (1.11 ± 005) to patients with COPD (1.57 ± 0.28) and were correlated with the degree of airflow obstruction (PFEV1 < 0.001).DiscussionIn this study, we observed an increased expression of ErbB receptors in patients with COPD, when compared to healthy smokers and controls. These data suggest that ErbB1–3 overexpression is not related only to smoking exposure but probably to epithelial remodelling and mucociliary system distortion, characterizing COPD. Additionally, the inverse correlation of ErbB4 with FEV1 exhibits a possible link between ErbB4 and COPD severity.
Degree
thesis:*- Grantor dc:publisher
- University of Crete (UOC)
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Anagnostis, Aristotelis
- Αναγνώστης, Αριστοτέλης
Subjects
dc:subject × 20- Χρόνια αποφρακτική πνευμονοπάθεια
- Υποδοχές του επιδερμικού αυξητικού παράγοντα
- Αυξητικοί παράγοντες
- Υπερέκκριση βλέννης
- Υπερπλασία καλυκοειδών κυτάρρων
- Ενδοκυτταρικά μονοπάτια μεταγωγής του σήματος
- Επιδιόρθωση τραυματισμένου βρογχικού επιθηλίου
- Βρογχικό επιθήλιο
- Chronic obstructive pulmonary disease
- Epidermal growth factor receptors
- Growth factors
- Mucous hypersecretion
- Goblet cells hyperplasia
- Cascade of signal transduction
- Repairing of bronchial epithelium injury
- Bronchial epithelium
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38931